SINAI HEALTH SYSTEM
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 2015-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
4
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Improving Diabetes Equity and Advancing Care Study
- Conditions
- Diabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetes
- First Posted Date
- 2023-09-15
- Last Posted Date
- 2023-12-07
- Lead Sponsor
- Sinai Health System
- Target Recruit Count
- 270
- Registration Number
- NCT06040463
- Locations
- 🇺🇸
Mount Sinai Hospital, Chicago, Illinois, United States
Helping Chicago's Westside Adults Breathe and Thrive
- Conditions
- Asthma
- First Posted Date
- 2018-04-05
- Last Posted Date
- 2018-04-05
- Lead Sponsor
- Sinai Health System
- Target Recruit Count
- 143
- Registration Number
- NCT03489655
- Locations
- 🇺🇸
Mount Sinai Hospital, Chicago, Illinois, United States
Controlling Hyperglycemia Among Minority Population
- Conditions
- Diabetes
- First Posted Date
- 2016-02-12
- Last Posted Date
- 2018-01-26
- Lead Sponsor
- Sinai Health System
- Target Recruit Count
- 272
- Registration Number
- NCT02681718
- Locations
- 🇺🇸
Mount Sinai Hospital, Chicago, Illinois, United States
News
Abbott's Groundbreaking AVEIR Leadless Pacemaker Shows Promise in First-in-Human Conduction System Pacing Study
Abbott's AVEIR Conduction System Pacing leadless pacemaker demonstrated successful implantation in the left bundle branch area of the heart in a first-of-its-kind feasibility study presented at HRS 2025.
BTL's Novel Catheter Shows Promise in Early Atrial Fibrillation Ablation
• BTL announced successful treatment of initial patients in a first-in-human study using a next-generation catheter for atrial fibrillation (AF) ablation. • The catheter system employs pulsed-field ablation (PFA) to enhance the safety, speed, and effectiveness of AF treatments. • Early results from six patients indicate the new catheter is safe, effective, and straightforward, aligning with preclinical study outcomes. • The novel catheter features single-shot pulmonary vein isolation (PVI) and is designed for intuitive placement, improving procedural reliability.